Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biological therapies in the systemic management of psoriasis: International Consensus Conference.
Sterry W, Barker J, Boehncke WH, Bos JD, Chimenti S, Christophers E, De La Brassinne M, Ferrandiz C, Griffiths C, Katsambas A, Kragballe K, Lynde C, Menter A, Ortonne JP, Papp K, Prinz J, Rzany B, Ronnevig J, Saurat JH, Stahle M, Stengel FM, Van De Kerkhof P, Voorhees J. Sterry W, et al. Among authors: de la brassinne m. Br J Dermatol. 2004 Aug;151 Suppl 69:3-17. doi: 10.1111/j.1365-2133.2004.06070.x. Br J Dermatol. 2004. PMID: 15265063 Free article. Review.
Scalp psoriasis: a review of current topical treatment options.
Papp K, Berth-Jones J, Kragballe K, Wozel G, de la Brassinne M. Papp K, et al. Among authors: de la brassinne m. J Eur Acad Dermatol Venereol. 2007 Oct;21(9):1151-60. doi: 10.1111/j.1468-3083.2007.02424.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17894698 Review.
A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G. Kragballe K, et al. Among authors: de la brassinne m. Br J Dermatol. 2006 Jun;154(6):1155-60. doi: 10.1111/j.1365-2133.2006.07236.x. Br J Dermatol. 2006. PMID: 16704648 Clinical Trial.
Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Williams Z, Peyri Rey J, Svensson A, Toole J, Wozel G. Kragballe K, et al. Among authors: de la brassinne m. Dermatology. 2006;213(4):319-26. doi: 10.1159/000096069. Dermatology. 2006. PMID: 17135738 Clinical Trial.
A Belgian consensus on the definition of a treat-to-target outcome set in psoriasis management.
Grine L, de la Brassinne M, Ghislain PD, Hillary T, Lambert J, Segaert S, Willaert F; Belgian Psoriasis T2T Specialist Group; Lambert J. Grine L, et al. Among authors: de la brassinne m. J Eur Acad Dermatol Venereol. 2020 Apr;34(4):676-684. doi: 10.1111/jdv.16104. Epub 2020 Jan 2. J Eur Acad Dermatol Venereol. 2020. PMID: 31749264 Free PMC article.
Congenital psoriasis following the lines of Blaschko.
Lehners-Weber C, de la Brassinne M, Dezfoulian B, Richert B, Bonardeaux C, Willemaers V. Lehners-Weber C, et al. Among authors: de la brassinne m. Pediatr Dermatol. 1996 May-Jun;13(3):219-21. doi: 10.1111/j.1525-1470.1996.tb01206.x. Pediatr Dermatol. 1996. PMID: 8806122
127 results